What is Crescent Cap Bdc's earnings per share (EPS)?

Crescent Cap Bdc (FCRX) reported diluted earnings per share of $1.81 for fiscal year 2025. This represents a -24.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Crescent Cap Bdc Financials

FCRX

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Crescent Cap Bdc (FCRX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating Crescent Cap Bdc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

4/6

Crescent Cap Bdc passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Cash-Backed

2.17x

For every $1 of reported earnings, Crescent Cap Bdc generates $2.17 in operating cash flow ($74.7M OCF vs $34.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

-1.7x

Crescent Cap Bdc earns $-1.7 in operating income for every $1 of interest expense (-$98.7M vs $57.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

$34.5M

YoY-53.1%

5Y CAGR-8.8%

Crescent Cap Bdc reported $34.5M in net income in fiscal year 2025. This represents a decrease of 53.1% from the prior year.

EPS (Diluted)

$1.81

YoY-24.6%

5Y CAGR+0.1%

Crescent Cap Bdc earned $1.81 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 24.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$5.0M

YoY-50.2%

5Y CAGR+23.6%

Crescent Cap Bdc held $5.0M in cash against $873.8M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

37M

YoY-0.2%

Crescent Cap Bdc had 37M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

4.9%

YoY-5.1pp

5Y CAGR-4.9pp

Crescent Cap Bdc's ROE was 4.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$1.3M

5Y CAGR-9.6%

Crescent Cap Bdc spent $1.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

N/A

FCRX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$98.7M+7.6%	-$106.8M-6.5%	-$100.3M-76.5%	-$56.8M-28.8%	-$44.1M-65.3%	-$26.7M
Interest Expense	$57.4M-8.5%	$62.8M+6.8%	$58.7M+84.3%	$31.9M+61.3%	$19.8M+27.6%	$15.5M
Income Tax	$6K-96.1%	$155K+400.0%	$31K+109.5%	-$326K-118.8%	$1.7M+3496.1%	-$51K
Net Income	$34.5M-53.1%	$73.6M-12.2%	$83.8M+439.4%	$15.5M-81.4%	$83.6M+53.0%	$54.7M
EPS (Diluted)	$1.81-24.6%	$2.40+4.3%	$2.30+19.2%	$1.93+15.6%	$1.67-7.2%	$1.80

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$21.9M	N/A	-$24.1M+6.1%	-$25.7M-2.8%	-$25.0M	N/A	-$27.4M-2.3%	-$26.8M
Interest Expense	$13.7M	N/A	$13.9M-8.4%	$15.2M+3.5%	$14.6M	N/A	$16.1M+1.1%	$15.9M
Income Tax	N/A	N/A	$0	$0-100.0%	$6K	N/A	$155K	$0
Net Income	-$15.5M	N/A	$7.1M-52.7%	$15.0M+284.6%	$3.9M	N/A	$15.3M-25.1%	$20.4M
EPS (Diluted)	$0.42	N/A	$0.460.0%	$0.46+2.2%	$0.45	N/A	$0.64+8.5%	$0.59

FCRX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$1.6B-2.1%	$1.7B+1.8%	$1.6B+24.9%	$1.3B-1.1%	$1.3B	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$5.0M-50.2%	$10.1M+30.2%	$7.8M+21.6%	$6.4M-36.5%	$10.1M+476.7%	$1.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$916.1M+0.1%	$915.6M+3.5%	$884.8M+28.2%	$690.3M+3.7%	$665.5M	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$873.8M-0.2%	$875.8M+3.7%	$844.8M+29.1%	$654.5M+3.7%	$631.0M	N/A
Total Equity	$706.0M-4.7%	$740.6M-0.3%	$742.6M+21.2%	$612.5M-6.1%	$652.3M+16.5%	$560.0M
Retained Earnings	-$251.0M-14.9%	-$218.5M+2.2%	-$223.3M-257.4%	-$62.5M-349.4%	-$13.9M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$1.6B-0.3%	$1.6B-0.3%	$1.6B-1.6%	$1.7B-0.7%	$1.7B+0.6%	$1.7B+0.7%	$1.6B-1.6%	$1.7B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$6.1M+21.7%	$5.0M-12.8%	$5.8M-40.6%	$9.7M-19.1%	$12.0M+18.8%	$10.1M-40.7%	$17.1M+55.1%	$11.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$943.6M+3.0%	$916.1M+0.3%	$913.6M-1.7%	$929.7M-1.0%	$939.4M+2.6%	$915.6M+2.2%	$896.2M-2.6%	$920.0M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$907.1M+3.8%	$873.8M-0.2%	$875.3M-1.4%	$887.3M-1.7%	$903.0M+3.1%	$875.8M+2.2%	$857.2M-2.6%	$879.9M
Total Equity	$674.0M-4.5%	$706.0M-1.1%	$714.1M-1.5%	$724.7M-0.3%	$727.1M-1.8%	$740.6M-1.1%	$748.8M-0.5%	$752.4M
Retained Earnings	-$282.0M-12.4%	-$251.0M-2.6%	-$244.7M-4.4%	-$234.4M-1.0%	-$232.0M-6.2%	-$218.5M-0.6%	-$217.1M-1.7%	-$213.5M

FCRX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$74.7M+26.8%	$58.9M-36.2%	$92.3M+230.2%	$28.0M+117.7%	-$157.7M-155.1%	-$61.8M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$82.5M-89.9%	-$43.5M+48.9%	-$85.0M-147.0%	-$34.4M-120.7%	$166.3M+163.1%	$63.2M
Dividends Paid	$67.8M-9.9%	$75.2M+16.6%	$64.5M+16.8%	$55.3M+15.8%	$47.7M+12.0%	$42.6M
Share Buybacks	$1.3M	N/A	N/A	N/A	N/A	$2.2M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$23.8M-205.1%	$22.6M-26.4%	$30.8M-15.6%	$36.4M+340.9%	-$15.1M-423.6%	-$2.9M-106.2%	$46.9M+290.5%	-$24.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$18.8M+199.2%	-$18.9M+34.9%	-$29.1M+29.0%	-$40.9M-745.2%	$6.3M+27.7%	$5.0M+111.0%	-$45.3M-257.3%	$28.8M
Dividends Paid	$15.5M-0.2%	$15.6M-10.6%	$17.4M-0.1%	$17.4M0.0%	$17.4M-4.1%	$18.2M-3.9%	$18.9M-1.9%	$19.3M
Share Buybacks	$1.0M0.0%	$1.0M	N/A	N/A	N/A	N/A	N/A	N/A

FCRX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	4.9%-5.1pp	9.9%-1.3pp	11.3%+8.8pp	2.5%-10.3pp	12.8%+3.1pp	9.8%
Return on Assets	2.1%-2.3pp	4.5%-0.7pp	5.1%+4.0pp	1.2%-5.2pp	6.3%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.24+0.1	1.18+0.0	1.14+0.1	1.07+0.1	0.97	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-2.3%	N/A	1.0%-1.1pp	2.1%+1.5pp	0.5%	N/A	2.0%-0.7pp	2.7%
Return on Assets	-1.0%	N/A	0.4%-0.5pp	0.9%+0.7pp	0.2%	N/A	0.9%-0.3pp	1.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.35+0.1	1.24+0.0	1.230.0	1.22-0.0	1.24+0.1	1.18+0.0	1.14-0.0	1.17
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

Is Crescent Cap Bdc profitable?

Yes, Crescent Cap Bdc (FCRX) reported a net income of $34.5M in fiscal year 2025.

How much debt does Crescent Cap Bdc have?

As of fiscal year 2025, Crescent Cap Bdc (FCRX) had $5.0M in cash and equivalents against $873.8M in long-term debt.

What is Crescent Cap Bdc's return on equity (ROE)?

Crescent Cap Bdc (FCRX) has a return on equity of 4.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Crescent Cap Bdc's operating cash flow?

Crescent Cap Bdc (FCRX) generated $74.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Crescent Cap Bdc's total assets?

Crescent Cap Bdc (FCRX) had $1.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Crescent Cap Bdc buy back shares?

Yes, Crescent Cap Bdc (FCRX) spent $1.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Crescent Cap Bdc have outstanding?

Crescent Cap Bdc (FCRX) had 37M shares outstanding as of fiscal year 2025.

What is Crescent Cap Bdc's debt-to-equity ratio?

Crescent Cap Bdc (FCRX) had a debt-to-equity ratio of 1.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Crescent Cap Bdc's return on assets (ROA)?

Crescent Cap Bdc (FCRX) had a return on assets of 2.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Crescent Cap Bdc's Piotroski F-Score?

Crescent Cap Bdc (FCRX) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Crescent Cap Bdc's earnings high quality?

Crescent Cap Bdc (FCRX) has an earnings quality ratio of 2.17x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Crescent Cap Bdc cover its interest payments?

Crescent Cap Bdc (FCRX) has an interest coverage ratio of -1.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.